Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news
HIV Therapy Should Start Sooner
|
MONDAY, Sept. 20 (HealthDayNews) -- Treatment of HIV should begin earlier than the current guidelines call for, says a study in the Sept. 15 issue of The Journal of Infectious Diseases. Current guidelines call for highly active antiretroviral therapy, or HAART, to begin when CD4 white blood cells drop below 200 per microliter of blood. But researchers from the New York Academy of Medicine and Johns Hopkins Bloomberg School of Public Health found results improved when the therapy began when CD4 levels were above 350 per microliter. "Our research is critically important because it shows that initiating HAART therapy in these patients when their CD4 counts are higher can save more lives and keep more of them from developing AIDS," said study co-author David Vlahov, director of the Academy Center for Urban Epidemiologic Studies and an adjunct professor at Johns Hopkins. More information The U.S. Centers for Disease Control and Prevention has more about HIV and AIDS.
|